Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery
Geoffrey J. Service, M.D., Geoffrey B. Thompson, M.D., F. John Service, M.D., Ph.D., James C. Andrews, M.D., Maria L. Collazo-Clavell, M.D., and Ricardo V. Lloyd, M.D., Ph.D.
We describe six patients (five women and one man; median age,47 years; range, 39 to 54) with postprandial symptoms of neuroglycopeniaowing to endogenous hyperinsulinemic hypoglycemia after Roux-en-Ygastric bypass surgery. Except for equivocal evidence in onepatient, there was no radiologic evidence of insulinoma. Selectivearterial calcium-stimulation tests, positive in each patient,were used to guide partial pancreatectomy. Nesidioblastosiswas identified in resected specimens from each patient, andmultiple insulinomas were identified in one. Hypoglycemic symptomsdiminished postoperatively. We speculate that hyperfunctionof pancreatic islets did not lead to obesity but that beta-celltrophic factors may have increased as a result of gastric bypass.
Source Information
From the Departments of Surgery (G.J.S., G.B.T.), Radiology (J.C.A.), and Pathology (R.V.L.) and the Division of Endocrinology, Metabolism, and Nutrition (F.J.S., M.L.C.-C.), Mayo Clinic and Foundation, Rochester, Minn.
Address reprint requests to Dr. F. John Service at the Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, or at service.john{at}mayo.edu.
Nauck, Michael. A., Vilsboll, T., Gallwitz, B., Garber, A., Madsbad, S.
(2009). Incretin-Based Therapies: Viewpoints on the way to consensus. Diabetes Care
32: S223-S231
[Full Text]
Purnell, J. Q., Flum, D. R.
(2009). Access to Bariatric Surgery and Patients With Diabetes--Reply. JAMA
302: 1056-1057
[Full Text]
Bloomgarden, Z. T.
(2009). The 6th Annual World Congress on the Insulin Resistance Syndrome. Diabetes Care
32: e104-e111
[Full Text]
Matveyenko, A. V., Dry, S., Cox, H. I., Moshtaghian, A., Gurlo, T., Galasso, R., Butler, A. E., Butler, P. C.
(2009). Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes: Interactions With Metformin. Diabetes
58: 1604-1615
[Abstract][Full Text]
Thaler, J. P., Cummings, D. E.
(2009). Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery. Endocrinology
150: 2518-2525
[Abstract][Full Text]
Ferrannini, E., Mingrone, G.
(2009). Impact of Different Bariatric Surgical Procedures on Insulin Action and {beta}-Cell Function in Type 2 Diabetes. Diabetes Care
32: 514-520
[Full Text]
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., Service, F. J.
(2009). Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab.
94: 709-728
[Abstract][Full Text]
Vidal, J., Nicolau, J., Romero, F., Casamitjana, R., Momblan, D., Conget, I., Morinigo, R., Lacy, A. M.
(2009). Long-Term Effects of Roux-en-Y Gastric Bypass Surgery on Plasma Glucagon-Like Peptide-1 and Islet Function in Morbidly Obese Subjects. J. Clin. Endocrinol. Metab.
94: 884-891
[Abstract][Full Text]
Padidela, R., Patterson, M., Sharief, N., Ghatei, M., Hussain, K.
(2009). Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period. Eur J Endocrinol
160: 53-58
[Abstract][Full Text]
Palladino, A. A., Sayed, S., Levitt Katz, L. E., Gallagher, P. R., De Leon, D. D.
(2009). Increased Glucagon-Like Peptide-1 Secretion and Postprandial Hypoglycemia in Children after Nissen Fundoplication. J. Clin. Endocrinol. Metab.
94: 39-44
[Abstract][Full Text]
Bult, M. J F, van Dalen, T., Muller, A. F
(2008). Surgical treatment of obesity. Eur J Endocrinol
158: 135-145
[Abstract][Full Text]
Rubino, F.
(2008). Is Type 2 Diabetes an Operable Intestinal Disease?: A provocative yet reasonable hypothesis. Diabetes Care
31: S290-S296
[Abstract][Full Text]
Cummings, D. E., Flum, D. R.
(2008). Gastrointestinal Surgery as a Treatment for Diabetes. JAMA
299: 341-343
[Full Text]
Vella, A., Service, F. J.
(2007). Incretin Hypersecretion in Post-Gastric Bypass Hypoglycemia Primary Problem or Red Herring?. J. Clin. Endocrinol. Metab.
92: 4563-4565
[Full Text]
Goldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., Patti, M. E.
(2007). Patients with Neuroglycopenia after Gastric Bypass Surgery Have Exaggerated Incretin and Insulin Secretory Responses to a Mixed Meal. J. Clin. Endocrinol. Metab.
92: 4678-4685
[Abstract][Full Text]
Sweet, M. P., Izumisato, Y., Way, L. W., Clark, O. H., Masharani, U., Duh, Q.-Y.
(2007). Laparoscopic Enucleation of Insulinomas. Arch Surg
142: 1202-1204
[Abstract][Full Text]
Holst, J. J.
(2007). The Physiology of Glucagon-like Peptide 1. Physiol. Rev.
87: 1409-1439
[Abstract][Full Text]
Bloomgarden, Z. T.
(2007). Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes. Diabetes Care
30: 1934-1939
[Full Text]
Wajchenberg, B. L.
(2007). {beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment. Endocr. Rev.
28: 187-218
[Abstract][Full Text]
Kauhanen, S., Seppanen, M., Minn, H., Gullichsen, R., Salonen, A., Alanen, K., Parkkola, R., Solin, O., Bergman, J., Sane, T., Salmi, J., Valimaki, M., Nuutila, P.
(2007). Fluorine-18-L-Dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography as a Tool to Localize an Insulinoma or {beta}-Cell Hyperplasia in Adult Patients. J. Clin. Endocrinol. Metab.
92: 1237-1244
[Abstract][Full Text]
Naslund, E., Kral, J. G.
(2006). Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes. Diabetes
55: S92-S97
[Abstract][Full Text]
Khoo, T.-K., Service, F. J.
(2006). 47-Year-Old Woman With Spells of Slurred Speech, Blurred Vision, and Loss of Consciousness. Mayo Clin Proc.
81: 1495-1498
[Full Text]
McMahon, M. M., Sarr, M. G., Clark, M. M., Gall, M. M., Knoetgen, J. III, Service, F. J., Laskowski, E. R., Hurley, D. L.
(2006). Clinical Management After Bariatric Surgery: Value of a Multidisciplinary Approach. Mayo Clin Proc.
81: S34-S45
[Abstract][Full Text]
Chaudhri, O., Small, C., Bloom, S.
(2006). Gastrointestinal hormones regulating appetite. Phil Trans R Soc B
361: 1187-1209
[Abstract][Full Text]
Meier, J. J., Butler, A. E., Galasso, R., Butler, P. C.
(2006). Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased {beta}-Cell Turnover. Diabetes Care
29: 1554-1559
[Abstract][Full Text]
Koehler, J. A., Drucker, D. J.
(2006). Activation of glucagon-like Peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells.. Diabetes
55: 1369-1379
[Abstract][Full Text]
Riddle, M. C., Drucker, D. J.
(2006). Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1. Diabetes Care
29: 435-449
[Full Text]
Scavini, M., Pontiroli, A. E., Folli, F.
(2005). Asymptomatic Hyperinsulinemic Hypoglycemia after Gastric Banding. NEJM
353: 2822-2823
[Full Text]
Carpenter, T., Trautmann, M. E., Baron, A. D., Kaiser, A. M., Service, F. J., Thompson, G. B., Lloyd, R. V., Cummings, D. E., Shannon, M. H., Carlson, M. J.
(2005). Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery. NEJM
353: 2192-2194
[Full Text]
Cummings, D. E.
(2005). Gastric Bypass and Nesidioblastosis -- Too Much of a Good Thing for Islets?. NEJM
353: 300-302
[Full Text]